These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23733394)

  • 41. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
    Galvin JE
    Acta Neuropathol; 2006 Aug; 112(2):115-26. PubMed ID: 16791599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
    Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
    Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.
    Ha Y; Yang A; Lee S; Kim K; Liew H; Lee SH; Lee JE; Lee HI; Suh YH; Park HS; Churchill DG
    J Neurosci Res; 2014 Mar; 92(3):359-68. PubMed ID: 24288134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. X-ray Crystallographic Structure of Oligomers Formed by a Toxic β-Hairpin Derived from α-Synuclein: Trimers and Higher-Order Oligomers.
    Salveson PJ; Spencer RK; Nowick JS
    J Am Chem Soc; 2016 Apr; 138(13):4458-67. PubMed ID: 26926877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.
    Fischer AF; Matera KM
    Neurochem Res; 2015 Jul; 40(7):1341-9. PubMed ID: 25956992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dynamic structure of α-synuclein multimers.
    Gurry T; Ullman O; Fisher CK; Perovic I; Pochapsky T; Stultz CM
    J Am Chem Soc; 2013 Mar; 135(10):3865-72. PubMed ID: 23398399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural Basis for Dityrosine-Mediated Inhibition of α-Synuclein Fibrillization.
    Sahin C; Østerlund EC; Österlund N; Costeira-Paulo J; Pedersen JN; Christiansen G; Nielsen J; Grønnemose AL; Amstrup SK; Tiwari MK; Rao RSP; Bjerrum MJ; Ilag LL; Davies MJ; Marklund EG; Pedersen JS; Landreh M; Møller IM; Jørgensen TJD; Otzen DE
    J Am Chem Soc; 2022 Jul; 144(27):11949-11954. PubMed ID: 35749730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Structural and Thermodynamic Analysis of Prefibrillar WT α-Synuclein and Its G51D, E46K, and A53T Mutants by a Combination of Small-Angle X-ray Scattering and Variational Bayesian Weighting.
    Moretti P; Mariani P; Ortore MG; Plotegher N; Bubacco L; Beltramini M; Spinozzi F
    J Chem Inf Model; 2020 Oct; 60(10):5265-5281. PubMed ID: 32866007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A small-angle X-ray scattering study of alpha-synuclein from human red blood cells.
    Araki K; Yagi N; Nakatani R; Sekiguchi H; So M; Yagi H; Ohta N; Nagai Y; Goto Y; Mochizuki H
    Sci Rep; 2016 Jul; 6():30473. PubMed ID: 27469540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.
    Huenchuguala S; Sjödin B; Mannervik B; Segura-Aguilar J
    Neurotox Res; 2019 Feb; 35(2):432-440. PubMed ID: 30343424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation and Characterization of Stable α-Synuclein Oligomers.
    Almandoz-Gil L; Ingelsson M; Bergström J
    Methods Mol Biol; 2018; 1779():61-71. PubMed ID: 29886527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small molecule inhibitors of alpha-synuclein filament assembly.
    Masuda M; Suzuki N; Taniguchi S; Oikawa T; Nonaka T; Iwatsubo T; Hisanaga S; Goedert M; Hasegawa M
    Biochemistry; 2006 May; 45(19):6085-94. PubMed ID: 16681381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of α-Synuclein Multimer Stoichiometry in Complex Biological Samples by Electrophoresis.
    Killinger BA; Moszczynska A
    Anal Chem; 2016 Apr; 88(7):4071-84. PubMed ID: 26937787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence of native α-synuclein conformers in the human brain.
    Gould N; Mor DE; Lightfoot R; Malkus K; Giasson B; Ischiropoulos H
    J Biol Chem; 2014 Mar; 289(11):7929-34. PubMed ID: 24474688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study.
    Curtain CC; Kirby NM; Mertens HD; Barnham KJ; Knott RB; Masters CL; Cappai R; Rekas A; Kenche VB; Ryan T
    Mol Biosyst; 2015 Jan; 11(1):190-6. PubMed ID: 25352253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.
    Abdullah R; Patil KS; Rosen B; Pal R; Prabhudesai S; Lee S; Basak I; Hoedt E; Yang P; Panick K; Ho HP; Chang E; Tzoulis C; Larsen JP; Neubert TA; Alves G; Møller SG
    Mol Neurobiol; 2017 Dec; 54(10):7639-7655. PubMed ID: 27837450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.
    Leong SL; Hinds MG; Connor AR; Smith DP; Illes-Toth E; Pham CL; Barnham KJ; Cappai R
    PLoS One; 2015; 10(2):e0116497. PubMed ID: 25679387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study.
    Pham CL; Kirby N; Wood K; Ryan T; Roberts B; Sokolova A; Barnham KJ; Masters CL; Knott RB; Cappai R; Curtain CC; Rekas A
    Proteins; 2014 Jan; 82(1):10-21. PubMed ID: 23733394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The structure of dopamine induced alpha-synuclein oligomers.
    Rekas A; Knott RB; Sokolova A; Barnham KJ; Perez KA; Masters CL; Drew SC; Cappai R; Curtain CC; Pham CL
    Eur Biophys J; 2010 Sep; 39(10):1407-19. PubMed ID: 20309679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.